Article
In vitro modeling of nutritional and mitochondria-targeted therapies for osteosarcoma
2026-02-20
Abstract excerpt
<h4>ABSTRACT</h4> Osteosarcoma is the most common pediatric bone tumor yet has limited treatment options, especially for metastatic cases with a 20% adjusted 5-year survival rate. Current therapies are non-specific, involving primary tumor resection with DNA-damaging chemotherapies like methotrexate, doxorubicin, and cisplatin. Few effective treatment options exist for metastases. Targeting metabolism involving c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 045ccefc-8758-5a0c-9a58-be061cabe8ee
- DOI
- 10.64898/2026.02.19.706776
